1-Bromo-3,5-dichlorobenzene

Catalog No.: 
ACMOKB254
CAS No.: 
19752-55-7
Molecular Formula: 
C6H3BrCl2
Molecular Weight: 
225.90
1-Bromo-3,5-dichlorobenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$138.00In stockInquiry
1000g98%$237.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Bromo-3,5-dichlorobenzene
IUPAC Name1-bromo-3,5-dichlorobenzene
MDL No.MFCD00000584
Molecular FormulaC6H3BrCl2
Molecular Weight225.90
SMILESC1=C(C=C(C=C1Cl)Cl)Br
InChI KeyDZHFFMWJXJBBRG-UHFFFAOYSA-N
Synonym1-Bromo-3,5-dichlorobenzene,98%;1-Bromo-3,5-dichloro;5-DichlorobroMobenzene;1-bromo-3,5-dichloro-benzen;3,5-DichL;orobromobenzene;3,5-dichloro-1-bromobenzene;1-BROMO-3,5-DICHLOROBENZENE
CAS No.19752-55-7
PubChem CID29766

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMOKB254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXGOD624 route compound structure diagram
    ACXGOD6243032-81-3In Stock
  4. Then
  5. ACMOKB254 route product structure diagram
    ACMOKB25419752-55-7In Stock
Inquiry

2. ACMOKB254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMOKB254 route compound structure diagram
    ACMOKB25419752-55-7In Stock
  4. Then
  5. ACMOKB254 route product structure diagram
    ACMOKB25419752-55-7In Stock
Inquiry

3. ACMOKB254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRPEN592 route compound structure diagram
    ACRPEN5921160573-64-7In Stock
  2. Then
  3. ACMOKB254 route product structure diagram
    ACMOKB25419752-55-7In Stock
Inquiry

Comments (0)